Phase I trial of ISA 106
Latest Information Update: 10 Mar 2021
At a glance
- Drugs ISA 106 (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- Sponsors ISA Pharmaceuticals
- 03 Mar 2021 According to the ISA Pharmaceuticals Media Release, this dose finding study in healthy volunteers will start in the next few months.
- 17 Feb 2021 New trial record